[1]
|
常敏, 张久聪, 周琴, 孙东辉, 汪泳.胃癌流行病学研究进展[J]. 胃肠病学和肝病学杂志, 2017, 26(9): 966-969.
|
[2]
|
Kim, S.T., Cristescu, R., Bass, A.J., Kim, K.-M., Odegaard, J.I., Kim, K., Liu, X.Q., Sher, X., Jung, H., Lee, M., Lee, S., Park, S.H., Park, J.O., Park, Y.S., Lim, H.Y., Lee, H., Choi, M., Talasaz, A.A., Kang, P.S., Cheng, J., Loboda, A., Lee, J. and Kang, W.K. (2018) Compre-hensive Molecular Characterization of Clinical Responses to PD-1 Inhibition in Metastatic Gastric Cancer. Nature Medicine, 24, 1449-1458. https://doi.org/10.1038/s41591-018-0101-z
|
[3]
|
Katona, B.W. and Rustgi, A.K. (2017) Gastric Cancer Genomics: Advances and Future Directions. Cellular and Molecular Gastroenterology and Hepatology, 3, 211-217. https://doi.org/10.1016/j.jcmgh.2017.01.003
|
[4]
|
杭渤, 束永前, 刘平, 魏光伟, 金健, 郝文山, 王培俊, 李斌, 毛建华. 肿瘤的精准医疗肿瘤的精准医疗: 概念、技术和展望[J]. 科技导报, 2015, 33(15): 14-21.
|
[5]
|
Chik, F., Szyf, M. and Rabbani, S.A. (2011) Role of Epigenetics in Cancer Initiation and Progression. Advances in Experimental Medicine and Biology, 720, 91-104.
|
[6]
|
Lim, B., Kim, H.-J., Heo, H., Huh, N., Baek, S.-J., Kim, J.-H., Bae, D.-H., Seo, E.-H., Lee, S.-I., Song, K.-S., Kim, S.-Y., Kim, Y.S. and Kim, M. (2018) Epigenetic Silencing of MiR-1271 Enhances MEK1 and TEAD4 Expression in Gastric Cancer. Cancer Medicine, 7, 3411-3424. https://doi.org/10.1002/cam4.1605
|
[7]
|
Lim, B., Kim, J.-H., Kim, M. and Kim, S.-Y. (2016) Genomic and Epigenomic Heterogeneity in Molecular Subtypes of Gastric Cancer. World Journal of Gastroenterology, 22, 1190-1201. https://doi.org/10.3748/wjg.v22.i3.1190
|
[8]
|
Riquelme, I., Tapia, O., Leal, P., Sandoval, A., Varga, M.G., Letelier, P., Buchegger, K., Bizama, C., Espinoza, J.A., Peek, R.M., Araya, J.C. and Roa, J.C. (2016) MiR-101-2, MiR-125b-2 and MiR-451a Act as Potential Tumor Suppressors in Gastric Cancer through Regulation of the PI3K/AKT/mTOR Pathway. Cellular Oncology, 39, 23-33.
https://doi.org/10.1007/s13402-015-0247-3
|
[9]
|
Wu, C., Zheng, X., Li, X., et al. (2016) Reduction of Gastric Cancer Prolifer-ation and Invasion by MiR-15a Mediated Suppression of Bmi-1 Translation. Oncotarget, 7, 14522-14536. https://doi.org/10.18632/oncotarget.7392
|
[10]
|
Hsu, K.-W., Wang, A.-M., Ping, Y.-H., Huang, K.-H., Huang, T.-T., Lee, H.-C., Lo, S.-S., Chi, C.-W. and Yeh, T.-S. (2013) Downregulation of Tumor Suppressor MBP-1 by MicroRNA-363 in Gastric Carcino-genesis. Carcinogenesis, 35, 208-217. https://doi.org/10.1093/carcin/bgt285
|
[11]
|
Whiti, R.T., Gurvinder, T., Katharine, D., Craig, L., Kathryn, F., Rebecca, A., Alpha, T., Michael, B. and Michael, G. (2018) The 2016 Revision of the WHO Classification of Central Nervous System Tumours: Retrospective Application to a Cohort of Diffuse Gliomas. Journal of Neuro-Oncology, 137, 181-189. https://doi.org/10.1007/s11060-017-2710-7
|
[12]
|
Del Corvo, M., Luini, M., Stella, A., Pagnacco, G., Ajmone-Marsan, P., Williams, J.L. and Minozzi, G. (2017) Identification of Additional Loci Associated with Antibody Response to Mycobacterium avium ssp. Paratuberculosis in Cattle by GSEA-SNP Analysis. Mammalian Genome, 28, 520-527. https://doi.org/10.1007/s00335-017-9714-7
|
[13]
|
Hang, D., Yuan, H., Liu, L., Wang, L., Miao, L., Zhu, M., Du, J., Dai, J., Hu, Z., Chen, N., Shen, H. and Ma, H. (2017) KIT Polymorphisms Were Associated with the Risk for Head and Neck Squamous Carci-noma in Chinese Population. Molecular Carcinogenesis, 56, 232-237. https://doi.org/10.1002/mc.22487
|
[14]
|
Matsuoka, T. and Yashiro, M. (2014) The Role of PI3K/Akt/mTOR Signaling in Gastric Carcinoma. Cancers, 6, 1441-1463. https://doi.org/10.3390/cancers6031441
|
[15]
|
Ge, Y., Liu, H., Qiu, X., Ma, G., Wang, H., Du, M., Wang, M., Zhao, Q., Tao, G., Chu, H. and Zhang, Z. (2018) Genetic Variants in PI3K/Akt/mTOR Pathway Genes Contribute to Gastric Cancer risk. Gene, 670, 130-135.
https://doi.org/10.1016/j.gene.2018.05.093
|
[16]
|
Graham, D.Y. (2015) Helicobacter Pylori Update: Gastric Cancer, Reliable Therapy, and Possible Benefits. Gastroenterology, 148, 719-731.e3. https://doi.org/10.1053/j.gastro.2015.01.040
|
[17]
|
McLean, M.H. and El-Omar, E.M. (2014) Genetics of Gastric Cancer. Nature Reviews. Gastroenterology & Hepatology, 11, 664-674. https://doi.org/10.1038/nrgastro.2014.143
|
[18]
|
Dina, S., Rasha, A., Sayed, A., Wael, F., Ahmed, E. and Azza, E. (2017) Erratum to: Braf, Kras and Helicobacter Pylori Epigenetic Changes-Associated Chronic Gastritis in Egyptian Patients with and without Gastric Cancer. World Journal of Microbiology & Biotechnology, 33, 100. https://doi.org/10.1007/s11274-017-2250-5
|
[19]
|
Liu, L. and Yang, X. (2015) Implication of Reprimo and hMLH1 Gene Methylation in Early Diagnosis of Gastric Carcinoma. International Journal of Clinical and Experimental Pathology, 8, 14977-14982.
|
[20]
|
Jin, J., Xie, L., Xie, C.H. and Zhou, Y.F. (2014) Aberrant DNA Methylation of MGMT and hMLH1 Genes in Prediction of Gastric Cancer. Genetics and Molecular Research, 13, 4140-4145. https://doi.org/10.4238/2014.May.30.9
|
[21]
|
Wang, M., Li, Y., Gao, J., Li, Y., Zhou, J., Gu, L., Shen, L. and Deng, D. (2014) p16 Methylation Is Associated with Chemosensitivity to Fluorouracil in Patients with Advanced Gastric Cancer. Medical Oncology, 31, 988.
https://doi.org/10.1007/s12032-014-0988-2
|
[22]
|
Song, J., Xie, H., Lian, Z., Yang, G., Du, R., Du, Y., Zou, X., Jin, H., Gao, J., Liu, J. and Fan, D. (2007) Enhanced Cell Survival of Gastric Cancer Cells by a Novel Gene URG4. Neoplasia, 8, 995-1002. https://doi.org/10.1593/neo.06592
|